Cargando…

Evaluation of lamb colostrum supplements

INTRODUCTION: Half of UK lamb mortality occurs within the first 24 hours of life, with newborn lambs requiring adequate intake of colostrum as soon as possible after birth to combat disease and optimise health. Approximately 22 percent of ewes produce colostrum of inadequate quality; consequently, c...

Descripción completa

Detalles Bibliográficos
Autor principal: Bond, Cherry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786255/
https://www.ncbi.nlm.nih.gov/pubmed/32994358
http://dx.doi.org/10.1136/vr.105763
_version_ 1783632588691210240
author Bond, Cherry
author_facet Bond, Cherry
author_sort Bond, Cherry
collection PubMed
description INTRODUCTION: Half of UK lamb mortality occurs within the first 24 hours of life, with newborn lambs requiring adequate intake of colostrum as soon as possible after birth to combat disease and optimise health. Approximately 22 percent of ewes produce colostrum of inadequate quality; consequently, colostrum replacers and supplements can be offered. Colostrum replacers should fully replace maternal colostrum, whereas colostrum supplements have been developed to provide exogenous immunoglobulins to neonates when natural concentrations are low and should contain a minimum of 3 g IgG/feed. METHODS: Fifteen different colostrum supplements were evaluated. For each product, two different batches were analysed for IgG content. RESULTS: Levels of IgG/feed ranged from 0.4 to 3.5 g. Products with the highest IgG levels were Lamaid (VetPlus), Colostro+ Lamb (Greencoat), Ovicol (Farmsense) and Shepherdess Lamb Colostrum (Provimi) averaging ≥3.0 g/feed. The remaining 11 products had IgG levels below 3 g IgG/feed, hence could be providing inadequate levels of IgG and potentially impacting on neonatal health. CONCLUSION: This study has shown great variability between the quality of commercially available colostrum supplements, so care must be taken when selecting products.
format Online
Article
Text
id pubmed-7786255
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-77862552021-01-14 Evaluation of lamb colostrum supplements Bond, Cherry Vet Rec Electronic pages INTRODUCTION: Half of UK lamb mortality occurs within the first 24 hours of life, with newborn lambs requiring adequate intake of colostrum as soon as possible after birth to combat disease and optimise health. Approximately 22 percent of ewes produce colostrum of inadequate quality; consequently, colostrum replacers and supplements can be offered. Colostrum replacers should fully replace maternal colostrum, whereas colostrum supplements have been developed to provide exogenous immunoglobulins to neonates when natural concentrations are low and should contain a minimum of 3 g IgG/feed. METHODS: Fifteen different colostrum supplements were evaluated. For each product, two different batches were analysed for IgG content. RESULTS: Levels of IgG/feed ranged from 0.4 to 3.5 g. Products with the highest IgG levels were Lamaid (VetPlus), Colostro+ Lamb (Greencoat), Ovicol (Farmsense) and Shepherdess Lamb Colostrum (Provimi) averaging ≥3.0 g/feed. The remaining 11 products had IgG levels below 3 g IgG/feed, hence could be providing inadequate levels of IgG and potentially impacting on neonatal health. CONCLUSION: This study has shown great variability between the quality of commercially available colostrum supplements, so care must be taken when selecting products. BMJ Publishing Group 2020-11-28 2020-11-26 /pmc/articles/PMC7786255/ /pubmed/32994358 http://dx.doi.org/10.1136/vr.105763 Text en © British Veterinary Association 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Electronic pages
Bond, Cherry
Evaluation of lamb colostrum supplements
title Evaluation of lamb colostrum supplements
title_full Evaluation of lamb colostrum supplements
title_fullStr Evaluation of lamb colostrum supplements
title_full_unstemmed Evaluation of lamb colostrum supplements
title_short Evaluation of lamb colostrum supplements
title_sort evaluation of lamb colostrum supplements
topic Electronic pages
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786255/
https://www.ncbi.nlm.nih.gov/pubmed/32994358
http://dx.doi.org/10.1136/vr.105763
work_keys_str_mv AT bondcherry evaluationoflambcolostrumsupplements